World Health Organization Issues Concern Over Acute Shortage of Weight-Loss Jabs

Less than a tenth of patients eligible to benefit from weight-loss injections including Wegovy have access to them, caution the global health agency as it publishes its initial advice on the drugs.

Considering more than one billion individuals worldwide currently obese, it is advocating for increased and just access to these injectable treatments.

Per forecasts, more than two billion could be obese by 2030 if no action is taken.

"Our latest guidelines acknowledges that excess weight is a chronic disease that can be addressed with comprehensive and lifelong care," remarked its chief Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and distribution challenges are significant hurdles to broad availability to the jabs that can assist patients in reducing substantial body mass, explains the organization.

Skinny Jab Supply Crisis

Despite the present best projected case, the manufacturing of such drugs might only reach about 100 million people – under 10% of eligible patients, per the health organization.

The guideline calls on countries and companies to increase availability, via measures including licensing agreements.

The intellectual property rights on the active ingredient – the main ingredient of a leading brand – is due to expire in several countries in 2026.

How Obesity Drugs Function

GLP-1 drugs imitate a natural hormone to reduce digestion speed, suppress the appetite and increase satiety so individuals eat less.

Patients usually see weight reduction within a few weeks of beginning the weekly injections.

Research points to people may put most of the weight back on a year later of stopping the medication, because their typical appetite come back.

To be carrying excess weight elevates your likelihood for developing diseases, such as type 2 diabetes, heart disease, stroke, and specific malignancies.

Excess weight concerns people in countries worldwide and was linked to millions of fatalities worldwide in 2024, according to the WHO.